Skip to Content
Search Site
Contact Us
Donate
Menu
Search Site
About Us
Board of Directors
Medical Advisors
What Is HypoPARA?
Symptoms & Treatment
Types & Causes
Newly Diagnosed?
Patient Stories
How to Help
Join Our Community
Donate
Volunteer
Advocacy
Resources
Patient Recommended Doctors
Important Links & Downloads
Videos & Webinars
Clinical Trials & Research
Social Security Disability Information
EL-PFDD
FAQs
International HypoPARA Organizations
News & Events
News
Events
Partners
Alexion, AstraZeneca Rare Disease
Ascendis
Bridgebio
MBX Biosciences
Orsini
Septerna
Takeda
Contact Us
Donate
Home
News & Events
News
Bridgebio announces the comple...
Bridgebio announces the completion of their Phase 3 Calibrate study for ADH1
February 17, 2025
Back to News
